Login to Your Account

Financings Roundup

Ziopharm Adds $31M For Clinical Oncology Pipeline

By Jennifer Boggs

Tuesday, February 20, 2007
Ziopharm Oncology Inc. pulled in gross proceeds of $30.9 million in a private placement to advance ongoing clinical development of three lead cancer programs, two of which are expected enter pivotal testing this year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription